Concurrent chemoradiotherapy treatment of locally advanced pancreatic cancer: Gemcitabine versus 5-fluorouracil, a randomized controlled study

This publication has 15 references indexed in Scilit:

• Phase I study of weekly gemcitabine as a radiation sensitizer for unresectable pancreatic cancer
  International Journal of Radiation Oncology*Biology*Physics, 2002
• Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?
  International Journal of Radiation Oncology*Biology*Physics, 2002
• Cancer Statistics, 2002
  CA: A Cancer Journal for Clinicians, 2002
• Phase I Trial of Radiation Dose Escalation With Concurrent Weekly Full-Dose Gemcitabine in Patients With Advanced Pancreatic Cancer
  Journal of Clinical Oncology, 2001
• Phase I study of twice-weekly gemcitabine and concomitant external-beam radiotherapy in patients with adenocarcinoma of the pancreas
  International Journal of Radiation Oncology*Biology*Physics, 2001
• Combining gemcitabine with radiation in pancreatic cancer: Understanding important variables influencing the therapeutic index
  Seminars in Oncology, 2001
• Gemcitabine following radiotherapy with concurrent 5‐fluorouracil for nonmetastatic adenocarcinoma of the pancreas
  International Journal of Cancer, 2001
• Eastern Cooperative Oncology Group Phase I Trial of Protracted Venous Infusion Fluorouracil Plus Weekly Gemcitabine With Concurrent Radiation Therapy in Patients With Locally Advanced Pancreas Cancer: A Regimen With Unexpected Early Toxicity
  Journal of Clinical Oncology, 2000
• Phase II study of gemcitabine (GEM) combined with radiation therapy (RT) in localized, unresectable pancreatic cancer
  European Journal Of Cancer, 1999
• Radiosensitization of pancreatic cancer cells by 2′,2′-difluoro-2′-deoxycytidine
  International Journal of Radiation Oncology*Biology*Physics, 1996